- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by MED Institute Inc.
Total 6418 results
-
MED Institute Inc.Active, not recruitingVenous Insufficiency of LegColombia
-
MED Institute Inc.CompletedOrthopedic Disorder | WoundUnited States
-
BeBetter Med IncCompletedRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Non-Hodgkin's LymphomaChina
-
BeBetter Med IncActive, not recruitingRelapsed or Refractory Diffuse Large B-cell LymphomaChina
-
BeBetter Med IncRecruitingRelapsed/Refractory Diffuse Large B-Cell LymphomaChina
-
BeBetter Med IncCompleted
-
EMD Serono Research & Development Institute, Inc.Terminated
-
EMD Serono Research & Development Institute, Inc.CompletedCarcinoma, Merkel CellUnited States, Spain, Australia, Italy, Germany, France, Japan
-
EMD Serono Research & Development Institute, Inc.CompletedRelapsing-Remitting Multiple SclerosisCroatia, United States, Bulgaria, France, Italy, Russian Federation, Turkey, United Kingdom, Estonia, Germany, Latvia, Lithuania, Poland, Austria, Brazil, Canada, Finland, Portugal, Greece, Serbia, Denmark, Ukraine, Saudi Arabia, Lebanon and more
-
EMD Serono Research & Development Institute, Inc.CompletedMultiple SclerosisUnited States, Italy, Russian Federation, Spain
-
EMD Serono Research & Development Institute, Inc.CompletedMultiple SclerosisLebanon, United States, Turkey, Sweden, Finland, France, Thailand, Serbia, Italy, United Kingdom, United Arab Emirates, Bulgaria, Belgium, Estonia, Argentina, Austria, Bosnia and Herzegovina, Canada, Croatia, Czechia, Georgia, Ger... and more
-
EMD Serono Research & Development Institute, Inc.Recruiting
-
Criterium, Inc.EMD Serono Research & Development Institute, Inc.TerminatedAdvanced Non-Small Cell Lung Cancer With MET MutationsUnited States
-
Radiomedix, Inc.Orano Med LLCRecruiting
-
XeltisQ-Med Scandinavia, Inc.CompletedHeart Defects, CongenitalRussian Federation
-
Radiomedix, Inc.Orano Med LLCActive, not recruitingNeuroendocrine TumorsUnited States
-
AbSolutions Med Inc.Cogent Technologies CorporationNot yet recruiting
-
Composite Interceptive Med ScienceBioxytran Inc.Completed
-
Mayo ClinicChek-Med Systems, Inc.Terminated
-
AbSolutions Med Inc.Cogent Technologies CorporationRecruiting
-
QED Therapeutics, Inc.RecruitingAchondroplasiaUnited States, Spain, Singapore, Canada, United Kingdom, France, Australia, Norway, Argentina, Germany, Italy
-
MEI Pharma, Inc.TerminatedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Marginal Zone B Cell Lymphoma | High Grade Non-Hodgkin's LymphomaUnited States, Switzerland
-
MEI Pharma, Inc.CompletedProstate CancerUnited States
-
QED Therapeutics, Inc.RecruitingHypochondroplasiaUnited States, Norway, Australia, Singapore, United Kingdom, Canada, France, Germany, Portugal, Spain, Sweden
-
QED Therapeutics, Inc.RecruitingAchondroplasiaUnited States, Spain, United Kingdom, France, Canada, Australia
-
MEI Pharma, Inc.RecruitingChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Acute Myeloid Leukemia (AML) | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Marginal Zone Lymphoma (MZL)United States
-
MEI Pharma, Inc.Active, not recruitingColorectal CancerUnited States
-
MEI Pharma, Inc.CompletedPeritoneal Neoplasms | Ovarian Cancer | Fallopian Tube CancerUnited States, Spain, Belgium, United Kingdom, Australia, Italy, Poland
-
MEI Pharma, Inc.CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States, Australia
-
QED Therapeutics, Inc.Enrolling by invitationAchondroplasiaUnited States, Spain, United Kingdom, France, Australia, Canada
-
QED Therapeutics, Inc.Enrolling by invitationAchondroplasiaAustralia, United States, Argentina, Canada, France, Germany, Italy, Norway, Singapore, Spain, United Kingdom
-
MEI Pharma, Inc.TerminatedMarginal Zone Lymphoma | Non Hodgkin Lymphoma | Follicular Lymphoma (FL)United States, Spain, Korea, Republic of, Belgium, Taiwan, Germany, France, Italy, Australia, Poland, New Zealand, United Kingdom, Austria, Switzerland
-
MED-LIFE DISCOVERIES LPBioPharma Services, IncRecruitingRhizomelic Chondrodysplasia PunctataCanada
-
South Shore HospitalQ-Med Scandinavia, Inc.Terminated
-
Raghu Nandan, M.D., IncUnknown
-
Jacob Soumerai, MDMEI Pharma, Inc.WithdrawnRelapsed Follicular Lymphoma | Refractory Follicular LymphomaUnited States
-
Raghu Nandan, M.D., IncUnknownCombination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerLung CancerUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyNot yet recruitingOvarian CancerUnited States, Germany
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyRecruitingDermatomyositis | PolymyositisUnited States, Italy, Spain, Greece, Czechia, United Kingdom, Poland
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedLymphoma | Refractory or Relapsed Solid TumorsKorea, Republic of, United States, Canada, Belgium, Denmark
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingA Study of Suboptimally Controlled Participants Previously Taking Injectable DMDs for RMS (CLICK-MS)Multiple SclerosisUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingSolid TumorsKorea, Republic of, United States, Spain, United Kingdom, Russian Federation, Argentina, Australia, Italy, Japan, Belgium, Brazil, Czechia, France, Germany, Hungary, Romania, Turkey, Bulgaria, Mexico, Poland, Thailand, Ukraine
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingSystemic Lupus ErythematosusKorea, Republic of, United States, Taiwan, China, Poland, Brazil, Argentina, Chile, Philippines, Australia, Colombia, Bulgaria, Mexico, Serbia, Greece, Spain, Israel, Japan, Mauritius, Moldova, Republic of, Romania, South Africa
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedSolid TumorsKorea, Republic of, United States, Belgium, Spain, Italy, Taiwan, Canada, Australia, United Kingdom, Germany, France, Japan
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedRelapsing-remitting Multiple SclerosisSpain, Czechia, Bulgaria, Serbia, Russian Federation, Ukraine, Poland, Slovakia
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedFirst Line Non-Small Cell Lung CancerSpain, United States, Hungary, Israel, China, Korea, Republic of, Taiwan, Czechia, Russian Federation, Australia, Brazil, Lebanon, Serbia, Thailand, Canada, Slovakia, Ukraine, Bulgaria, Italy, Netherlands, New Zealand, Poland, Belgium, Turk... and more
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedCervical CancerUnited States, Spain, Japan
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingNon-small Cell Lung CancerUnited States, Korea, Republic of, Taiwan, Spain, Hong Kong, Argentina, China, Netherlands, France, Brazil, Belgium, Canada, Germany, Greece, Italy, Japan, Turkey, Ukraine
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompleted
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminated